Search Within

Afsheen Naz Iqbal

Formats
  1. Meeting Abstract (12)
  2. Journal Article (10)
Groups
  1. Department of Medicine (22)
  2. Solid Tumor Oncology Division (22)
  3. Thoracic Oncology (22)
  4. Weinberg Fellows (15)
  5. GSK Faculty (13)
  6. Body Imaging Service (11)

More Groups

People
  1. Juliana Eng (11)
  2. Mark Kris (11)
  3. Kenneth Ng (10)
  4. Gregory Riely (9)
  5. Paul Paik (9)
  6. Andreas Rimner (8)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (6)
  2. Journal of Thoracic Oncology (4)
  3. Annals of Oncology (2)
  4. Clinical Cancer Research (2)
  5. Clinical Lung Cancer (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (12)
  2. American Society of Clinical Oncology (4)
  3. American Association for Cancer Research (2)
  4. Oxford University Press (2)
  5. Elsevier BV (1)
  6. Nature Publishing Group (1)

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC
    Meeting Abstract

    Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A phase I study of cyclical hypofractionated palliative radiation (Quad Shot) for lung tumors in patients with stage IV non-small cell lung cancer (NSCLC): Results from the PROMISE 006 trial
    Meeting Abstract

    Zhang, H. Y.; Iqbal, A.; Yang, J. T.; Gillespie, E. F.; Toumbacaris, N.; Zhang, Z.; Brooks, P.; Khalyat, E.; Shaverdian, N.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Lebow, E. S.; Fitzgerald, K. J.; Shaverdian, N.; Kotecha, R.; Gomez, D. R.; Wu, A. J.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; Zhang, Z.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
    Journal Article

    Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A phase 1 safety study of avelumab plus stereotactic body radiation therapy in malignant pleural mesothelioma
    Journal Article

    Rimner, A.; Adusumilli, P. S.; Offin, M. D.; Solomon, S. B.; Ziv, E.; Hayes, S. A.; Ginsberg, M. S.; Sauter, J. L.; Gelblum, D. Y.; Shepherd, A. F.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Planned interim analysis of a phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Rimner, A.; Fitzgerald, K.; Iqbal, A. N.; Shepherd, A. F.; Gomez, D. R.; Shin, J. Y.; Gelblum, D. Y.; Hajj, C.; Albrecht, F.; Kotecha, R. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save